Go back

Japanese companies and DNDi team up against neglected diseases

Image: e-Magine Art [CC BY 2.0], via Flickr

The Drugs For Neglected Diseases Initiative has joined forces with three Japanese and one UK-based multinational pharmaceutical companies to carry out collaborative research into neglected tropical diseases.

The four pharmaceutical companies—Eisai, Shionogi, Takeda Pharmaceuticals, and AstraZeneca—and DNDi will focus on leishmaniasis and Chagas disease, both of which are problems in Africa

The Japanese partners will be supported by DNDi with €640,000 (US$700,000) from the Global Health Innovative Technology Fund, a collaboration between the Bill & Melinda Gates Foundation, the Japanese government and six Japanese pharmaceutical companies.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.